Francis Wheeler

Cooley advised Nanjing Leads Biolabs Co. (Leads Biolabs), a clinical-stage biotechnology company that discovers, develops and commercializes new therapies in oncology, autoimmune and other severe diseases, on its HK$1.29 billion initial public offering (IPO).

Cooley advised the underwriters of Caris Life Sciences, a patient-centric, next-generation artificial intelligence techbio company and precision medicine pioneer, in connection with Caris’ $494 million initial public offering (IPO).

Cooley advised Bitdeer Technologies Group (Nasdaq: BTDR), a top technology company for blockchain and high-performance computing, on its $330 million principal amount of 4.875% convertible senior notes due 2031.

Cooley advised AIRO Group Holdings, a company specializing in advanced aerospace and defense technologies, on its $69 million initial public offering (IPO).

Cooley advised Xometry, the global artificial intelligence-powered marketplace connecting buyers with suppliers of manufacturing services, on its $250 million aggregate principal amount of 0.75% convertible senior notes due 2030, which includes the initial purchasers’ option to purchase up to an additional $25 million aggregate principal amount of notes.